Menu
Back to Journals » Cancer Management and Research » Volume 9
Original Research
Comparison of gefitinib as first- and second-line therapy for advanced lung adenocarcinoma patients with positive exon 21 or 19 del epidermal growth factor receptor mutation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,395 | Dovepress* | 7,774+ | 1,265 | 9,039 | |
| PubMed Central* | 621 | 209 | 830 | ||
| Totals | 8,395 | 1,474 | 9,869 | ||
| *Since 28 June 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed Central and Google Scholar